Cargando…
Metyrosine-associated endocrinological changes in pheochromocytoma and paraganglioma
OBJECTIVE: Metyrosine (alpha-methyl-para-tyrosine) effectively reduces catecholamine levels in patients with pheochromocytoma/paraganglioma. However, improvements in physiological and metabolic parameters and changes in endocrine function associated with metyrosine administration should be validated...
Autores principales: | Matsuo, Yuko, Ashida, Kenji, Nagayama, Ayako, Moritaka, Kanoko, Gobaru, Mizuki, Yasuda, Junichi, Ogasawara, Naoyuki, Kurose, Hirofumi, Chikui, Katsuaki, Iwata, Shimpei, Inoguchi, Yukihiro, Hasuzawa, Nao, Motomura, Seiichi, Igawa, Tsukasa, Nomura, Masatoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bioscientifica Ltd
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563611/ https://www.ncbi.nlm.nih.gov/pubmed/37822367 http://dx.doi.org/10.1530/EO-23-0006 |
Ejemplares similares
-
Metreleptin Supplementation for Improving Lipid and Glycemic Profiles in Acquired Diabetes Lipodystrophy: A Case Report
por: Nagayama, Ayako, et al.
Publicado: (2019) -
Human Leukocyte Antigen (HLA) Subtype-Dependent Development of Myasthenia Gravis, Type-1 Diabetes Mellitus, and Hashimoto Disease: A Case Report of Autoimmune Polyendocrine Syndrome Type 3
por: Gobaru, Mizuki, et al.
Publicado: (2019) -
Case Report: Metreleptin and SGLT2 Inhibitor Combination Therapy Is Effective for Acquired Incomplete Lipodystrophy
por: Nagayama, Ayako, et al.
Publicado: (2021) -
Eruptive xanthomas as a marker for metabolic disorders: A specific form of xanthoma that reflects hypertriglyceridemia
por: Ohtaki, Sohichiroh, et al.
Publicado: (2022) -
Paraganglioma of the urinary bladder: Case report and literature review
por: Kurose, Hirofumi, et al.
Publicado: (2020)